| MeSH term | MeSH ID | Detail |
|---|---|---|
| Keratosis, Actinic | D055623 | 3 associated lipids |
| Invasive Pulmonary Aspergillosis | D055744 | 1 associated lipids |
| Latent Tuberculosis | D055985 | 1 associated lipids |
| Netherton Syndrome | D056770 | 1 associated lipids |
| Leukoencephalopathies | D056784 | 3 associated lipids |
| Central Serous Chorioretinopathy | D056833 | 1 associated lipids |
| Thrombotic Microangiopathies | D057049 | 1 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
| Candidiasis, Invasive | D058365 | 2 associated lipids |
| End Stage Liver Disease | D058625 | 1 associated lipids |
| Retrognathia | D063173 | 1 associated lipids |
| Drug-Related Side Effects and Adverse Reactions | D064420 | 3 associated lipids |
| Scorpion Stings | D065008 | 1 associated lipids |
tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (2)
- J. Pharmacol. Exp. Ther. (1)
- Am. J. Physiol. Renal Physiol. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ohye H et al. | Effects of immunosuppressant agents on growth hormone release and gene expression. | 1998 | Endocr. J. | pmid:9790238 |
| Casavilla FA et al. | Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. | 1998 | Liver Transpl Surg | pmid:9791154 |
| Toshima K et al. | Effect of FK506 on the activation state of hepatic macrophages in Propionibacterium acnes-treated rats. | 1998 | J. Gastroenterol. Hepatol. | pmid:9792034 |
| Sengoku T et al. | [Effects of tacrolimus ointment on type I (immediate and late) and IV (delayed) cutaneous allergic reactions in mice]. | 1998 | Nippon Yakurigaku Zasshi | pmid:9793077 |
| Hashimoto Y et al. | Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats. | 1998 | Pharm. Res. | pmid:9794505 |
| Kobayashi M et al. | Effects of FK506 on experimental membranous glomerulonephritis induced by cationized bovine serum albumin in rats. | 1998 | Nephrol. Dial. Transplant. | pmid:9794552 |
| Schaefer A et al. | Stimulation of the Ca2+-mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A. | 1998 | Biochem. J. | pmid:9794788 |
| Whitcup SM et al. | Topical liposome-encapsulated FK506 for the treatment of endotoxin-induced uveitis. | 1998 | Ocul. Immunol. Inflamm. | pmid:9798194 |
| Sankary HN et al. | FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. | 1998 | Transplantation | pmid:9798690 |
| Garcia-Criado FJ et al. | Possible tacrolimus action mechanisms in its protector effects on ischemia-reperfusion injury. | 1998 | Transplantation | pmid:9798713 |
| Fisher NC | Renal failure after lung transplantation. | 1998 | Lancet | pmid:9800782 |
| Conti F et al. | Low level of interleukin 10 synthesis during liver allograft rejection. | 1998 | Lab. Invest. | pmid:9800954 |
| Reis A et al. | A comparative investigation of FK506 and cyclosporin A in murine corneal transplantation. | 1998 | Graefes Arch. Clin. Exp. Ophthalmol. | pmid:9801895 |
| Bieber T | Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis. | 1998 | J. Allergy Clin. Immunol. | pmid:9802361 |
| Boguniewicz M et al. | A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. | 1998 | J. Allergy Clin. Immunol. | pmid:9802373 |
| Faure JD et al. | An Arabidopsis immunophilin, AtFKBP12, binds to AtFIP37 (FKBP interacting protein) in an interaction that is disrupted by FK506. | 1998 | Plant J. | pmid:9807817 |
| Cardenas ME et al. | Signal-transduction cascades as targets for therapeutic intervention by natural products. | 1998 | Trends Biotechnol. | pmid:9807840 |
| Hultsch T et al. | Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. | 1998 | Arch. Dermatol. Res. | pmid:9808344 |
| Cacciarelli TV et al. | Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. | 1998 | Transplantation | pmid:9808490 |
| Nakazawa Y et al. | Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation. | 1998 | Transplantation | pmid:9808496 |